Hemolytic uremic syndrome in pediatric intensive care units in são paulo, Brazil

Renato Lopes de Souza1, João Tomás Abreu Carvalhaes, Lucilia Sanae Nishimura

  • 1Pediatric Intensive Care Unit, Department of Pediatrics, Universidade Federal de São Paulo, São Paulo, Brazil.

Insights

Shiga toxin-producing Escherichia coli (STEC) causes hemolytic uremic syndrome (HUS) in children, leading to acute renal failure. This study highlights the prevalence of STEC O157 in São Paulo HUS cases, emphasizing the need for early diagnosis and treatment.

Area of Science:

  • Pediatric Nephrology
  • Infectious Diseases
  • Microbiology

Background:

  • Hemolytic uremic syndrome (HUS) is a leading cause of acute renal failure in children.
  • Shiga toxin-producing Escherichia coli (STEC) is a primary pathogen responsible for post-diarrheal HUS.
  • Understanding STEC serotypes and their clinical impact is crucial for pediatric care.

Purpose of the Study:

  • To investigate the clinical and microbiological features of 13 pediatric HUS cases in São Paulo, Brazil.
  • To identify STEC strains and associated serological markers in HUS patients.
  • To highlight the role of specific STEC serotypes, particularly O157, in HUS etiology.

Main Methods:

  • Collected epidemiologic, clinical, and laboratory data from HUS patients.
  • Analyzed fecal samples for STEC isolation and identified genetic sequences of Shiga toxin (Stx).
  • Assessed serum samples for antibodies against lipopolysaccharide (LPS) O26, O111, and O157.

Main Results:

  • STEC was identified in 3 patients (serotypes O26:H11, O157:H7, O165:H-).
  • Elevated IgM against LPS O111 (n=2) and O157 (n=7) was detected in 9 patients.
  • Combined methods confirmed STEC infection in 92.3% of cases; O157 STEC was notably prevalent.

Conclusions:

  • Combined microbiologic and serologic methods effectively diagnose STEC-associated HUS.
  • Shiga toxin-producing E. coli O157 is a significant, previously underestimated cause of HUS in São Paulo.
  • Early identification and management of STEC infections are vital in pediatric acute renal failure cases.

Related Concept Videos

Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...